These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 31814020)
1. Ethnicity-specific and overlapping alterations of brain hydroxymethylome in Alzheimer's disease. Qin L; Xu Q; Li Z; Chen L; Li Y; Yang N; Liu Z; Guo J; Shen L; Allen EG; Chen C; Ma C; Wu H; Zhu X; Jin P; Tang B Hum Mol Genet; 2020 Jan; 29(1):149-158. PubMed ID: 31814020 [TBL] [Abstract][Full Text] [Related]
2. Global changes in DNA methylation and hydroxymethylation in Alzheimer's disease human brain. Coppieters N; Dieriks BV; Lill C; Faull RL; Curtis MA; Dragunow M Neurobiol Aging; 2014 Jun; 35(6):1334-44. PubMed ID: 24387984 [TBL] [Abstract][Full Text] [Related]
3. Altered hydroxymethylome in the substantia nigra of Parkinson's disease. Min S; Xu Q; Qin L; Li Y; Li Z; Chen C; Wu H; Han J; Zhu X; Jin P; Tang B Hum Mol Genet; 2022 Oct; 31(20):3494-3503. PubMed ID: 35661211 [TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease. Chen L; Shen Q; Xu S; Yu H; Pei S; Zhang Y; He X; Wang Q; Li D J Alzheimers Dis; 2022; 85(2):573-585. PubMed ID: 34864677 [TBL] [Abstract][Full Text] [Related]
5. Role of TET1-mediated epigenetic modulation in Alzheimer's disease. Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656 [TBL] [Abstract][Full Text] [Related]
6. Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma. Liu H; Xu T; Cheng Y; Jin MH; Chang MY; Shu Q; Allen EG; Jin P; Wang X DNA Cell Biol; 2019 Dec; 38(12):1460-1469. PubMed ID: 31657619 [TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer's disease modulate Tau-induced neurotoxicity. Bernstein AI; Lin Y; Street RC; Lin L; Dai Q; Yu L; Bao H; Gearing M; Lah JJ; Nelson PT; He C; Levey AI; Mullé JG; Duan R; Jin P Hum Mol Genet; 2016 Jun; 25(12):2437-2450. PubMed ID: 27060332 [TBL] [Abstract][Full Text] [Related]
8. Neurofilament-labeled pyramidal neurons and astrocytes are deficient in DNA methylation marks in Alzheimer's disease. Phipps AJ; Vickers JC; Taberlay PC; Woodhouse A Neurobiol Aging; 2016 Sep; 45():30-42. PubMed ID: 27459923 [TBL] [Abstract][Full Text] [Related]
9. Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease. Zhang Y; Zhang Z; Li L; Xu K; Ma Z; Chow HM; Herrup K; Li J FASEB J; 2020 Dec; 34(12):16364-16382. PubMed ID: 33058355 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide alteration of 5-hydroxymenthylcytosine in a mouse model of Alzheimer's disease. Shu L; Sun W; Li L; Xu Z; Lin L; Xie P; Shen H; Huang L; Xu Q; Jin P; Li X BMC Genomics; 2016 May; 17():381. PubMed ID: 27207465 [TBL] [Abstract][Full Text] [Related]
11. Alterations in the Genomic Distribution of 5hmC in In Vivo Aged Human Skin Fibroblasts. Kołodziej-Wojnar P; Borkowska J; Wicik Z; Domaszewska-Szostek A; Połosak J; Cąkała-Jakimowicz M; Bujanowska O; Puzianowska-Kuznicka M Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374812 [TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood. Lardenoije R; Roubroeks JAY; Pishva E; Leber M; Wagner H; Iatrou A; Smith AR; Smith RG; Eijssen LMT; Kleineidam L; Kawalia A; Hoffmann P; Luck T; Riedel-Heller S; Jessen F; Maier W; Wagner M; Hurlemann R; Kenis G; Ali M; Del Sol A; Mastroeni D; Delvaux E; Coleman PD; Mill J; Rutten BPF; Lunnon K; Ramirez A; van den Hove DLA Clin Epigenetics; 2019 Nov; 11(1):164. PubMed ID: 31775875 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA. Skvortsova K; Zotenko E; Luu PL; Gould CM; Nair SS; Clark SJ; Stirzaker C Epigenetics Chromatin; 2017; 10():16. PubMed ID: 28428825 [TBL] [Abstract][Full Text] [Related]
14. Age-related epigenome-wide DNA methylation and hydroxymethylation in longitudinal mouse blood. Kochmanski J; Marchlewicz EH; Cavalcante RG; Sartor MA; Dolinoy DC Epigenetics; 2018; 13(7):779-792. PubMed ID: 30079798 [TBL] [Abstract][Full Text] [Related]
15. Alterations in global DNA methylation and hydroxymethylation are not detected in Alzheimer's disease. Lashley T; Gami P; Valizadeh N; Li A; Revesz T; Balazs R Neuropathol Appl Neurobiol; 2015 Jun; 41(4):497-506. PubMed ID: 25201696 [TBL] [Abstract][Full Text] [Related]
16. A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease. Zhao J; Zhu Y; Yang J; Li L; Wu H; De Jager PL; Jin P; Bennett DA Alzheimers Dement; 2017 Jun; 13(6):674-688. PubMed ID: 28089213 [TBL] [Abstract][Full Text] [Related]
17. Integrated analyses of 5 mC, 5hmC methylation and gene expression reveal pathology-associated AKT3 gene and potential biomarkers for Alzheimer's disease. Shen Y; Zhu W; Li S; Zhang Z; Zhang J; Li M; Zheng W; Wang D; Zhong Y; Li M; Zheng H; Du J J Psychiatr Res; 2024 Oct; 178():367-377. PubMed ID: 39197298 [TBL] [Abstract][Full Text] [Related]
18. Single-Base Resolution Mapping of 5-Hydroxymethylcytosine Modifications in Hippocampus of Alzheimer's Disease Subjects. Ellison EM; Bradley-Whitman MA; Lovell MA J Mol Neurosci; 2017 Oct; 63(2):185-197. PubMed ID: 28866733 [TBL] [Abstract][Full Text] [Related]
19. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease. Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171 [TBL] [Abstract][Full Text] [Related]
20. DNMT3B Is an Oxygen-Sensitive De Novo Methylase in Human Mesenchymal Stem Cells. Dogan F; Aljumaily RMK; Kitchen M; Forsyth NR Cells; 2021 Apr; 10(5):. PubMed ID: 33925659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]